Halozyme Therapeutics Inc
|
|
N/A
|
4.38M
$0
|
|
|
|
$16.01 - $18.91
$336 - $397
|
37
$0
|
|
|
|
$6.82 - $8.79
$34.1 - $43.9
|
45
$0
|
|
|
|
$20.03 - $25.22
$40.1 - $50.4
|
52
$1K
|
|
|
|
N/A
|
1.25M
$0
|
|
|
|
N/A
|
7.87K
$0
|
|
|
|
N/A
|
19.6K
$0
|
|
Hive Digital Technologies Lt
|
|
N/A
|
131K
$0
|
|
Howard Hughes Holdings Inc
|
|
N/A
|
321K
$0
|
|
|
|
N/A
|
125K
$0
|
|
|
|
N/A
|
93
$0
|
|
|
|
$1.6 - $1.85
$205 - $237
|
199
$0
|
|
|
|
N/A
|
1.02M
$0
|
|
|
|
N/A
|
41K
$0
|
|
|
|
N/A
|
1.65M
$0
|
|
|
|
$5.35 - $7.06
$647 - $854
|
1.09K
$7K
|
|
|
|
N/A
|
4.6K
$0
|
|
|
|
N/A
|
786K
$0
|
|
|
|
N/A
|
557K
$0
|
|
Intensity Therapeutics Inc
|
|
N/A
|
49
$0
|
|
Invesco Actively Managed Exc
|
|
N/A
|
60.5K
$0
|
|
|
|
N/A
|
869K
$0
|
|
Invesco Exch Traded Fd Tr Ii
|
|
N/A
|
155K
$0
|
|
|
|
$97.34 - $111.39
$45.9K - $52.6K
|
4.65K
$516K
|
|
|
|
N/A
|
29.1K
$0
|
|
Invesco Exch Traded Fd Tr Ii
|
|
N/A
|
62.9K
$0
|
|
|
|
N/A
|
16.2K
$0
|
|
|
|
N/A
|
137K
$0
|
|
|
|
N/A
|
25.3K
$0
|
|
|
|
N/A
|
617K
$0
|
|
|
|
N/A
|
4.57K
$0
|
|
|
|
N/A
|
105K
$0
|
|
|
|
N/A
|
6.8K
$0
|
|
|
|
N/A
|
348K
$0
|
|
|
|
N/A
|
1.03K
$0
|
|
|
|
N/A
|
477K
$0
|
|
|
|
N/A
|
2.98K
$0
|
|
|
|
N/A
|
34.7K
$0
|
|
|
|
$69.46 - $77.48
$208 - $232
|
135
$10K
|
|
|
|
N/A
|
1.35M
$0
|
|
J P Morgan Exchange Traded F
|
|
N/A
|
57
$0
|
|
|
|
N/A
|
8.3K
$0
|
|
|
|
$7.13 - $8.27
$1.15K - $1.33K
|
2.1K
$17K
|
|
|
|
N/A
|
3.77M
$0
|
|
John Bean Technologies Corp
|
|
N/A
|
2.82M
$0
|
|
|
|
N/A
|
304
$0
|
|
|
|
N/A
|
52M
$0
|
|
|
|
$33.14 - $55.62
$66.3 - $111
|
17
$0
|
|
Kiniksa Pharmaceuticals Intl
|
|
N/A
|
211K
$0
|
|
|
|
N/A
|
454
$0
|
|